| Value | ₹60.90 Cr |
|---|
BSE filing, BSE: 543787. Summary written from the filing by ALFA Finder's alert engine.
Macfos Ltd: key numbers
- Share price
- ₹1,137.95
- Market cap
- ₹1,179 Cr
- Revenue (annual)
- ₹308.8 Cr
- Net profit (annual)
- ₹25.64 Cr
- P/E (TTM)
- 46.0×Sector 23.5×
- Promoter holding
- 69.12%+0.00% QoQ
- FII holding
- 0.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Macfos Ltd
All →Macfos Investor Presentation: Key Takeaways
H1 FY27 revenue ₹181.96 Cr (+41%), EBITDA ₹21.91 Cr (+34%), PAT ₹13.18 Cr (+31%) on comparable Ind AS basis. Growth driven by ROBU 1.0 e-commerce core, with ROBU 2.0 proprietary drone and product push.
Macfos Other Announcement
Macfos Limited's board voluntarily constituted a Risk Management Committee with three members, effective immediately. The committee's terms of reference were also approved.
Macfos Q2 FY27 Results: Net Profit ₹7.4 Cr, Up 45.1% YoY
Macfos Ltd reported revenue from operations of ₹98.7 Cr (+44.1% YoY) and net profit of ₹7.4 Cr (+45.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.4 Cr · +45.1% YoY
Macfos Board Meeting Date
Macfos Limited scheduled a board meeting on 28th October 2026 to consider and approve its unaudited standalone and consolidated financial results.
Macfos Other Announcement
Macfos Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per SEBI disclosure requirements.
Macfos Annual General Meeting
Macfos Ltd filed its 9th AGM proceedings, clarifying a BSE portal OTP-related delay. Routine items including audited financials and director re-appointment were passed.
Other bonus issue announcements
All →Shivalik Bimetal Controls Bonus Issue
Shivalik Bimetal added a bonus share proposal and interim dividend to its 04 November 2026 board agenda. Trading window remains closed until 06 November 2026.
Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.